Data / Form D filings / Trilinear BioVentures, LLC
Trilinear BioVentures, LLC: Form D filing
Trilinear BioVentures, LLC, a biotechnology company in Huntsville, AL, filed a Form D with the SEC in 2023. The latest, on April 14, 2023, reports $6,000 sold of a $5 million offering to 1 investor.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 601 GENOME WAY, SUITE 2003, Huntsville, AL, 35806
- Phone
- (256) 210-1190
- Industry
- Biotechnology
- Entity type
- Limited Liability Company
- Incorporated in
- Alabama
- Year incorporated
- 2020
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1972886
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Apr 14, 2023 | New notice | $5,000,000 | $6,000 | $4,994,000 | 1 | Mar 30, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Keith Johnson | Executive Officer, Director | |
| Dennis L. Olive, Sr. | Director |
Other biotechnology companies in Alabama that filed recently
- Khaya Biosciences, Inc. $200,000 · Aug 13, 2026
Every Form D from the week of Apr 10, 2023 · All recent filings in Alabama · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Trilinear BioVentures, LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.